Cytiva, formerly part of GE Healthcare Life Sciences (JA-830)
| Audit # | JA-830 |
|---|---|
| Region | Sweden |
| Standards | Basic Chemicals/Raw Materials |
| Company | Cytiva, formerly part of GE Healthcare Life Sciences |
| Location | (Biosciences AB) Bjorkgatan 30, Uppsala SE-751 84, |
| Date | April 17-18, 2018 |
| Materials | Phenyl Sepharose HP171082xx Phenyl Sepharose 6 FF170965xx/170973xx Butyl Sepharose 4 FF Butyl Sepharose HP170980xx Q- Sepharose FF175432xx Q Sepharose XL170510xx Q Sepharose HP175072xx Cm Sepharose FF171014xx Cm Sepharose HP170719xx Sp Sepharose HP171277xx Sp Sepharose FF171087xx DEAE Sepharose FF170729xx nProtein A Sepharose 4FF170709xx Sephacryl S-500 HR175280xx Sephacryl S200-HR170613xx MabSelect SuRe170584xx MabSelect175438xx175199xx Superdex 200 PG171043xx Capto Adhere175444xx Capto L175478xx |
* If you do not have access to auditsPLUS database and would like to join this audit contact Simone Ziss at sziss@rx-360.org
* If you do not have access to auditsPLUS database and would like to license this audit contact Jaye Greene at jgreene@rx-360.org